Related Experiment Video

Updated: Mar 7, 2026

A Manual Small Molecule Screen Approaching High-throughput Using Zebrafish Embryos
07:45

A Manual Small Molecule Screen Approaching High-throughput Using Zebrafish Embryos

Published on: November 8, 2014

18.3K

Erratum to: Zebrafish phenotypic screen identifies novel Notch antagonists

Vithya Velaithan1, Kazuhide Shaun Okuda1, Mei Fong Ng1

  • 1Cancer Research Malaysia, 12A, Jalan TP5, Taman Perindustrian UEP, 47600, Subang Jaya, Malaysia.

Investigational New Drugs
|February 11, 2017
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Shifting Zebrafish Lethal Skeletal Mutant Penetrance by Progeny Testing
08:39

Shifting Zebrafish Lethal Skeletal Mutant Penetrance by Progeny Testing

Published on: September 1, 2017

8.2K
Large Scale Zebrafish-Based In vivo Small Molecule Screen
07:03

Large Scale Zebrafish-Based In vivo Small Molecule Screen

Published on: December 30, 2010

14.1K

Related Experiment Videos

Last Updated: Mar 7, 2026

A Manual Small Molecule Screen Approaching High-throughput Using Zebrafish Embryos
07:45

A Manual Small Molecule Screen Approaching High-throughput Using Zebrafish Embryos

Published on: November 8, 2014

18.3K
Shifting Zebrafish Lethal Skeletal Mutant Penetrance by Progeny Testing
08:39

Shifting Zebrafish Lethal Skeletal Mutant Penetrance by Progeny Testing

Published on: September 1, 2017

8.2K
Large Scale Zebrafish-Based In vivo Small Molecule Screen
07:03

Large Scale Zebrafish-Based In vivo Small Molecule Screen

Published on: December 30, 2010

14.1K

Related Concept Videos

Genetic Screens02:46

Genetic Screens

5.8K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.8K

Articles linked to this work by shared authors, journal, and citation graph.

Integrated Experimental and Computational Profiling of Curcumin-Derived Diarylpentanoids Reveals Mechanistic Determinants of COX1/COX2 Inhibition and Selectivity.

ACS omega·2026

NMR-based metabolomics of Indonesian jamu for diabetes: chemical composition, toxicity, and zebrafish behavioral impact.

Natural product research·2026

A Review of Curcuminoid Derivatives as Next-Generation Depigmenting Agents: Structure-activity Relationships and their Mechanisms.

Current medicinal chemistry·2026

In Vitro and In Vivo Evaluation of Chaetoceros sp. Immunomodulatory Effects in Red Hybrid Tilapia, Oreochromis spp.

Biology·2026

1H NMR-based metabolomics reveals bioactive compounds from the diatom Halamphora sp. extracted with different solvents.

Preparative biochemistry & biotechnology·2026

Unlocking the Potential of Phyllanthus Species From Traditional Knowledge to Clinical Trials: An Updated Review of Metabolomics Approach in Diabetes Intervention.

Phytotherapy research : PTR·2026

Characterizing the post-market safety profile of lazertinib: a pharmacovigilance study of the FDA Adverse Events Reporting System Database.

Investigational new drugs·2026

A first-in-human phase 1a study of LP-184, a tumor-site activated novel alkylating agent, in patients with advanced solid tumors.

Investigational new drugs·2026

Evaluating pegenzileukin (SAR444245/THOR-707) in combination with pembrolizumab or cetuximab in advanced metastatic gastrointestinal cancer: the PEGATHOR phase 2 study.

Investigational new drugs·2026

Characterizing the post-market safety profile of cemiplimab: a pharmacovigilance study of the FDA adverse events reporting system database.

Investigational new drugs·2026

Clinical features, diagnosis and prognosis of nivolumab-associated fulminant type 1 diabetes.

Investigational new drugs·2026

Allogeneic hematopoietic stem cell transplantation with liposomal mitoxantrone conditioning for extramedullary leukemia.

Investigational new drugs·2026

Successful Re-challenge of zongertinib following erythema multiforme-like drug eruption in a patient with HER2-mutant non-small cell lung cancer.

Respiratory medicine case reports·2026

Erratum: [Corrigendum] CDDO, a PPAR-γ ligand, inhibits TPA-induced cell migration and invasion through a PPAR-γ-independent mechanism.

Oncology letters·2026

Correction to: An Uncommon Adverse Event of Endoscopic Vacuum Therapy and Pigtail Stent Placement for the Treatment of Bariatric Surgery Leak.

ACG case reports journal·2026

Correction: Delgado-Núñez et al. Isorhamnetin: A Nematocidal Flavonoid from Prosopis laevigata Leaves Against Haemonchus contortus Eggs and Larvae. Biomolecules 2020, 10, 773.

Biomolecules·2026

Correction.

Journal of pharmaceutical policy and practice·2026

Liquid volume fraction and droplet sizing in atomizing sprays using polarization ratio with dual structured laser illumination planar imaging: erratum.

Optics letters·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us